| |
| |
|
| Insider
Information: |
Paggiarino Dario A. |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
67,080 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$29,683 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
67,080 |
|
|
| Total
Value |
$29,683 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
EyePoint Pharmaceuticals Inc |
EYPT |
|
2024-03-30 |
67,080 |
2018-03-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
8,333 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
18,333 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
16,667 |
32,055 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2019-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,200 |
42,612 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2019-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
48,437 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2020-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,200 |
57,247 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2020-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
63,079 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2020-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
41,050 |
101,193 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,105 |
13,015 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2021-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,420 |
13,012 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2022-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,966 |
17,561 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,105 |
19,945 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,800 |
29,451 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,285 |
40,992 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,800 |
47,305 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-03-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,404 |
92,626 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2020-06-30 |
4 |
D |
$0.76 |
$9,121 |
D/D |
(12,049) |
89,144 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2020-06-27 |
4 |
D |
$0.79 |
$2,317 |
D/D |
(2,936) |
60,143 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2020-06-14 |
4 |
D |
$0.83 |
$3,441 |
D/D |
(4,168) |
53,079 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2019-06-14 |
4 |
D |
$1.53 |
$6,388 |
D/D |
(4,175) |
38,437 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2019-06-27 |
4 |
D |
$1.65 |
$4,851 |
D/D |
(2,940) |
45,497 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-06-27 |
4 |
D |
$1.86 |
$5,478 |
D/D |
(2,945) |
15,388 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2019-10-12 |
4 |
D |
$2.11 |
$5,157 |
D/D |
(2,450) |
43,047 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2019-03-19 |
4 |
D |
$2.47 |
$2,934 |
D/D |
(1,188) |
28,412 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-10-12 |
4 |
D |
$3.23 |
$7,930 |
D/D |
(2,455) |
29,600 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
